Future studies should concentrate to confirm RASSF10 down regulation by promoter hypermethylation in MCC, as epigenetic inactivation of RASSF10 was earlier reported in different cancer cell lines and primary tumors [24,26,27,42,43]. This evidence concerns the gene RASSF10 and cancer.